A股異動 | 威帝股份(603023.SH)漲超5% 控股權擬變更
格隆匯9月16日丨威帝股份(603023.SH)開盤一度漲停,現漲幅收窄至5.21%,報5.25元,暫成交9229萬元,最新總市值29.5億元。威帝股份昨日發佈公告稱,股東陳振華、陳慶華、劉國平與麗水久有基金簽署協議,擬將其合計持有的上市公司1.2億股股份轉讓給後者,該部分股份佔公司總股本的比例為21.43%,轉讓價格為6.23元/股,較最新股價4.99元溢價24.85%。若本次交易得以順利實施,則公司控股股東將變更為麗水久有股權投資基金合夥企業(有限合夥),實際控制人將變更為麗水經濟技術開發區管理委員會。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.